Maze Therapeutics Inc. MAZE
$23.77
▼ -0.17% 24H
About
Maze Therapeutics Inc. is a clinical-stage biopharmaceutical company developing small molecule precision medicines for renal, cardiovascular, related metabolic diseases, and obesity. The company harnesses human genetics through its Compass platform to identify genetic variants in diseases and link them to biological pa…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees141
TickerMAZE
Statistics
Market Cap$1.18B
Revenue (TTM)$18.2M
Net Income-$131.1M
Net Margin-718.8%
EPS$-3.05
P/E189.50
P/S64.81
P/B3.38
EV/EBITDA-7.83
ROE-38.7%
Dividend Yield—
Price$23.77
Data: Twelve Data · Revenue = mcap / P/S